ラボラトリー機器の市場規模、シェア、動向分析レポート:製品別(一般、分析、臨床、サポート、特殊)、エンドユース別(研究機関、ヘルスケア、獣医)、地域別、セグメント別予測、2023年~2030年Laboratory Equipment Market Size, Share & Trends Analysis Report By Product (General, Analytical, Clinical, Support, Specialty), By End-use (Research Institutions, Healthcare, Veterinary), By Region, And Segment Forecasts, 2023 - 2030 検査機器市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界のラボラトリー機器市場規模は2030年までに502億7000万米ドルに達し、予測期間中のCAGRは7.62%を記録すると推定されている... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー検査機器市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界のラボラトリー機器市場規模は2030年までに502億7000万米ドルに達し、予測期間中のCAGRは7.62%を記録すると推定されている。研究活動を支援するための政府研究費と投資の増加、バイオテクノロジーと製薬産業の成長の増加、技術の進歩などの主な要因が市場の成長を促進している。 特にバイオテクノロジー企業における政府の研究資金や投資の増加は、研究活動を支援し、実験装置の必要性を高める上で重要な役割を果たしている。例えば、2023年3月、英国政府は、医療診断とヒト用医薬品の製造プロジェクトを推進するため、ライフサイエンス企業への3億5,168万米ドルの資金提供を発表した。 こうした投資や政府の研究資金により、研究者や研究機関は研究に必要な実験機器に投資することができる。これらの資金は科学研究の取り組みを促進するために使用され、ひいては市場の成長を増大させる。これらの業界は、研究開発への投資を頻繁に行っており、その中には実験装置の購入も含まれる。 検査機器分野における技術の進歩も、市場の成長を促す要因の一つである。ワークフローと効率を向上させるため、自動化技術が実験装置に組み込まれている。例えば、2022年1月、MGI Tech Co.Ltd.は自動サンプル前処理システムMGISP-Smart 8を発売した。MGISP-Smart 8は独立した分注ロボットである。これらの進歩は、実験装置の機能性、効率性、能力を大幅に向上させた。 ラボラトリー機器市場レポートハイライト - 2022年、製品別では一般機器が最大の市場シェアを占める。これは、幅広い用途、実験、費用対効果により、さまざまな研究分野で汎用性の高い選択肢となっているため。 - 最終用途別では、診断検査、医学研究、医薬品開発の需要の高まりにより、ヘルスケア分野が2022年に最大の収益シェアを占めた。 - 北米では、米国やカナダなどの国々で研究活動を支援するための投資や政府研究資金が増加していることから、予測期間中に最も速いCAGRが見込まれる。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. End-use 1.1.3. Regional scope 1.1.4. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. End-use outlook 2.2.3. Regional outlook 2.3. Competitive Insights Chapter 3. Laboratory Equipment Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Rising investments and government research funding to support research activities 3.4.1.2. Increasing growth of biotechnology and pharmaceutical industries 3.4.1.3. Technological advancements in the field of laboratory equipment 3.4.2. Market restraint analysis 3.4.2.1. High cost of technologically advanced laboratory equipment 3.5. Laboratory Equipment Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Laboratory Equipment Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. General 4.1.2. Analytical 4.1.3. Clinical 4.1.4. Support 4.1.5. Specialty 4.2. Product Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Laboratory Equipment Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. General 4.5.1.1. General market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Analytical 4.5.2.1. Analytical market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Clinical 4.5.3.1. Clinical market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Support 4.5.4.1 Support market estimates and forecast 2018 to 2030 (USD Million) 4.5.5 Specialty 4.5.5.1 Specialty market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Laboratory Equipment Market: End-use Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Research Institutions 5.1.2. Healthcare 5.1.3. Veterinary 5.1.4. Others 5.2. End-use Market Share, 2022 & 2030 5.3. Segment Dashboard 5.4. Laboratory Equipment Market by End-use Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Research Institutions 5.5.1.1. Research Institutions market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Healthcare 5.5.2.1. Healthcare market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Veterinary 5.5.3.1 Veterinary market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Others 5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Laboratory Equipment Market: Regional Estimates & Trend Analysis 6.1. Regional market share analysis, 2022 & 2030 6.2. Regional Market Dashboard 6.3. Global Regional Market Snapshot 6.4. Regional Market Share and Leading Players, 2022 6.4.1. North America 6.4.2. Europe 6.4.3. Asia Pacific 6.4.4. Latin America 6.4.5. Middle East and Africa 6.5. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030: 6.6. North America 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 6.6.2. U.S. 6.6.2.1. Key country dynamics 6.6.2.2. Competitive Scenario 6.6.2.3. Regulatory framework 6.6.2.4. Reimbursement scenario 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 6.6.3. Canada 6.6.3.1. Key country dynamics 6.6.3.2. Competitive Scenario 6.6.3.3. Regulatory framework 6.6.3.4. Reimbursement scenario 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030 6.7. Europe 6.7.1. UK 6.7.1.1. Key country dynamics 6.7.1.2. Competitive Scenario 6.7.1.3. Regulatory framework 6.7.1.4. Reimbursement scenario 6.7.1.5. UK market estimates and forecasts, 2018 - 2030 6.7.2. Germany 6.7.2.1. Key country dynamics 6.7.2.2. Competitive Scenario 6.7.2.3. Regulatory framework 6.7.2.4. Reimbursement scenario 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030 6.7.3. France 6.7.3.1. Key country dynamics 6.7.3.2. Competitive Scenario 6.7.3.3. Regulatory framework 6.7.3.4. Reimbursement scenario 6.7.3.5. France market estimates and forecasts, 2018 - 2030 6.7.4. Italy 6.7.4.1. Key country dynamics 6.7.4.2. Competitive Scenario 6.7.4.3. Regulatory framework 6.7.4.4. Reimbursement scenario 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030 6.7.5. Spain 6.7.5.1. Key country dynamics 6.7.5.2. Competitive Scenario 6.7.5.3. Regulatory framework 6.7.5.4. Reimbursement scenario 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030 6.7.6. Denmark 6.7.6.1. Key country dynamics 6.7.6.2. Competitive Scenario 6.7.6.3. Regulatory framework 6.7.6.4. Reimbursement scenario 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 6.7.7. Sweden 6.7.7.1. Key country dynamics 6.7.7.2. Competitive Scenario 6.7.7.3. Regulatory framework 6.7.7.4. Reimbursement scenario 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 6.7.8. Norway 6.7.8.1. Key country dynamics 6.7.8.2. Competitive Scenario 6.7.8.3. Regulatory framework 6.7.8.4. Reimbursement scenario 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030 6.8. Asia Pacific 6.8.1. Japan 6.8.1.1. Key country dynamics 6.8.1.2. Competitive Scenario 6.8.1.3. Regulatory framework 6.8.1.4. Reimbursement scenario 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030 6.8.2. India 6.8.2.1. Key country dynamics 6.8.2.2. Competitive Scenario 6.8.2.3. Regulatory framework 6.8.2.4. Reimbursement scenario 6.8.2.5. India market estimates and forecasts, 2018 - 2030 6.8.3. China 6.8.3.1. Key country dynamics 6.8.3.2. Competitive Scenario 6.8.3.3. Regulatory framework 6.8.3.4. Reimbursement scenario 6.8.3.5. China market estimates and forecasts, 2018 - 2030 6.8.4. South Korea 6.8.4.1. Key country dynamics 6.8.4.2. Competitive Scenario 6.8.4.3. Regulatory framework 6.8.4.4. Reimbursement scenario 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 6.8.5. Australia 6.8.5.1. Key country dynamics 6.8.5.2. Competitive Scenario 6.8.5.3. Regulatory framework 6.8.5.4. Reimbursement scenario 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030 6.8.6. Thailand 6.8.6.1. Key country dynamics 6.8.6.2. Competitive Scenario 6.8.6.3. Regulatory framework 6.8.6.4. Reimbursement scenario 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 6.9. Latin America 6.9.1. Brazil 6.9.1.1. Key country dynamics 6.9.1.2. Competitive Scenario 6.9.1.3. Regulatory framework 6.9.1.4. Reimbursement scenario 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 6.9.2. Mexico 6.9.2.1. Key country dynamics 6.9.2.2. Competitive Scenario 6.9.2.3. Regulatory framework 6.9.2.4. Reimbursement scenario 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 6.9.3. Argentina 6.9.3.1. Key country dynamics 6.9.3.2. Competitive Scenario 6.9.3.3. Regulatory framework 6.9.3.4. Reimbursement scenario 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 6.10. MEA 6.10.1. South Africa 6.10.1.1. Key country dynamics 6.10.1.2. Competitive Scenario 6.10.1.3. Regulatory framework 6.10.1.4. Reimbursement scenario 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 6.10.2. Saudi Arabia 6.10.2.1. Key country dynamics 6.10.2.2. Competitive Scenario 6.10.2.3. Regulatory framework 6.10.2.4. Reimbursement scenario 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 6.10.3. UAE 6.10.3.1. Key country dynamics 6.10.3.2. Competitive Scenario 6.10.3.3. Regulatory framework 6.10.3.4. Reimbursement scenario 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030 6.10.4. Kuwait 6.10.4.1. Key country dynamics 6.10.4.2. Competitive Scenario 6.10.4.3. Regulatory framework 6.10.4.4. Reimbursement scenario 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Market Participants 7.2. Company/Competition Categorization 7.2.1. Innovators 7.3. Vendor Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.3.3. Key company market share analysis, 2022 7.3.4. Sartorius AG 7.3.4.1. Company overview 7.3.4.2. Financial performance 7.3.4.3. Product benchmarking 7.3.4.4. Strategic initiatives 7.3.5. Bio-Rad Laboratories, Inc. 7.3.5.1. Company overview 7.3.5.2. Financial performance 7.3.5.3. Product benchmarking 7.3.5.4. Strategic initiatives 7.3.6. FUJIFILM Holdings Corporation 7.3.6.1. Company overview 7.3.6.2. Financial performance 7.3.6.3. Product benchmarking 7.3.6.4. Strategic initiatives 7.3.7. Thermo Fisher Scientific, Inc. 7.3.7.1. Company overview 7.3.7.2. Financial performance 7.3.7.3. Product benchmarking 7.3.7.4. Strategic initiatives 7.3.8. Agilent Technologies, Inc. 7.3.8.1. Company overview 7.3.8.2. Financial performance 7.3.8.3. Product benchmarking 7.3.8.4. Strategic initiatives
SummaryLaboratory Equipment Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. End-use 1.1.3. Regional scope 1.1.4. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. End-use outlook 2.2.3. Regional outlook 2.3. Competitive Insights Chapter 3. Laboratory Equipment Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Rising investments and government research funding to support research activities 3.4.1.2. Increasing growth of biotechnology and pharmaceutical industries 3.4.1.3. Technological advancements in the field of laboratory equipment 3.4.2. Market restraint analysis 3.4.2.1. High cost of technologically advanced laboratory equipment 3.5. Laboratory Equipment Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Laboratory Equipment Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. General 4.1.2. Analytical 4.1.3. Clinical 4.1.4. Support 4.1.5. Specialty 4.2. Product Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Laboratory Equipment Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. General 4.5.1.1. General market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Analytical 4.5.2.1. Analytical market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Clinical 4.5.3.1. Clinical market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Support 4.5.4.1 Support market estimates and forecast 2018 to 2030 (USD Million) 4.5.5 Specialty 4.5.5.1 Specialty market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Laboratory Equipment Market: End-use Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Research Institutions 5.1.2. Healthcare 5.1.3. Veterinary 5.1.4. Others 5.2. End-use Market Share, 2022 & 2030 5.3. Segment Dashboard 5.4. Laboratory Equipment Market by End-use Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Research Institutions 5.5.1.1. Research Institutions market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Healthcare 5.5.2.1. Healthcare market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Veterinary 5.5.3.1 Veterinary market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Others 5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Laboratory Equipment Market: Regional Estimates & Trend Analysis 6.1. Regional market share analysis, 2022 & 2030 6.2. Regional Market Dashboard 6.3. Global Regional Market Snapshot 6.4. Regional Market Share and Leading Players, 2022 6.4.1. North America 6.4.2. Europe 6.4.3. Asia Pacific 6.4.4. Latin America 6.4.5. Middle East and Africa 6.5. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030: 6.6. North America 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 6.6.2. U.S. 6.6.2.1. Key country dynamics 6.6.2.2. Competitive Scenario 6.6.2.3. Regulatory framework 6.6.2.4. Reimbursement scenario 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 6.6.3. Canada 6.6.3.1. Key country dynamics 6.6.3.2. Competitive Scenario 6.6.3.3. Regulatory framework 6.6.3.4. Reimbursement scenario 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030 6.7. Europe 6.7.1. UK 6.7.1.1. Key country dynamics 6.7.1.2. Competitive Scenario 6.7.1.3. Regulatory framework 6.7.1.4. Reimbursement scenario 6.7.1.5. UK market estimates and forecasts, 2018 - 2030 6.7.2. Germany 6.7.2.1. Key country dynamics 6.7.2.2. Competitive Scenario 6.7.2.3. Regulatory framework 6.7.2.4. Reimbursement scenario 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030 6.7.3. France 6.7.3.1. Key country dynamics 6.7.3.2. Competitive Scenario 6.7.3.3. Regulatory framework 6.7.3.4. Reimbursement scenario 6.7.3.5. France market estimates and forecasts, 2018 - 2030 6.7.4. Italy 6.7.4.1. Key country dynamics 6.7.4.2. Competitive Scenario 6.7.4.3. Regulatory framework 6.7.4.4. Reimbursement scenario 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030 6.7.5. Spain 6.7.5.1. Key country dynamics 6.7.5.2. Competitive Scenario 6.7.5.3. Regulatory framework 6.7.5.4. Reimbursement scenario 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030 6.7.6. Denmark 6.7.6.1. Key country dynamics 6.7.6.2. Competitive Scenario 6.7.6.3. Regulatory framework 6.7.6.4. Reimbursement scenario 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 6.7.7. Sweden 6.7.7.1. Key country dynamics 6.7.7.2. Competitive Scenario 6.7.7.3. Regulatory framework 6.7.7.4. Reimbursement scenario 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 6.7.8. Norway 6.7.8.1. Key country dynamics 6.7.8.2. Competitive Scenario 6.7.8.3. Regulatory framework 6.7.8.4. Reimbursement scenario 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030 6.8. Asia Pacific 6.8.1. Japan 6.8.1.1. Key country dynamics 6.8.1.2. Competitive Scenario 6.8.1.3. Regulatory framework 6.8.1.4. Reimbursement scenario 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030 6.8.2. India 6.8.2.1. Key country dynamics 6.8.2.2. Competitive Scenario 6.8.2.3. Regulatory framework 6.8.2.4. Reimbursement scenario 6.8.2.5. India market estimates and forecasts, 2018 - 2030 6.8.3. China 6.8.3.1. Key country dynamics 6.8.3.2. Competitive Scenario 6.8.3.3. Regulatory framework 6.8.3.4. Reimbursement scenario 6.8.3.5. China market estimates and forecasts, 2018 - 2030 6.8.4. South Korea 6.8.4.1. Key country dynamics 6.8.4.2. Competitive Scenario 6.8.4.3. Regulatory framework 6.8.4.4. Reimbursement scenario 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 6.8.5. Australia 6.8.5.1. Key country dynamics 6.8.5.2. Competitive Scenario 6.8.5.3. Regulatory framework 6.8.5.4. Reimbursement scenario 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030 6.8.6. Thailand 6.8.6.1. Key country dynamics 6.8.6.2. Competitive Scenario 6.8.6.3. Regulatory framework 6.8.6.4. Reimbursement scenario 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 6.9. Latin America 6.9.1. Brazil 6.9.1.1. Key country dynamics 6.9.1.2. Competitive Scenario 6.9.1.3. Regulatory framework 6.9.1.4. Reimbursement scenario 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 6.9.2. Mexico 6.9.2.1. Key country dynamics 6.9.2.2. Competitive Scenario 6.9.2.3. Regulatory framework 6.9.2.4. Reimbursement scenario 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 6.9.3. Argentina 6.9.3.1. Key country dynamics 6.9.3.2. Competitive Scenario 6.9.3.3. Regulatory framework 6.9.3.4. Reimbursement scenario 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 6.10. MEA 6.10.1. South Africa 6.10.1.1. Key country dynamics 6.10.1.2. Competitive Scenario 6.10.1.3. Regulatory framework 6.10.1.4. Reimbursement scenario 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 6.10.2. Saudi Arabia 6.10.2.1. Key country dynamics 6.10.2.2. Competitive Scenario 6.10.2.3. Regulatory framework 6.10.2.4. Reimbursement scenario 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 6.10.3. UAE 6.10.3.1. Key country dynamics 6.10.3.2. Competitive Scenario 6.10.3.3. Regulatory framework 6.10.3.4. Reimbursement scenario 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030 6.10.4. Kuwait 6.10.4.1. Key country dynamics 6.10.4.2. Competitive Scenario 6.10.4.3. Regulatory framework 6.10.4.4. Reimbursement scenario 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Market Participants 7.2. Company/Competition Categorization 7.2.1. Innovators 7.3. Vendor Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.3.3. Key company market share analysis, 2022 7.3.4. Sartorius AG 7.3.4.1. Company overview 7.3.4.2. Financial performance 7.3.4.3. Product benchmarking 7.3.4.4. Strategic initiatives 7.3.5. Bio-Rad Laboratories, Inc. 7.3.5.1. Company overview 7.3.5.2. Financial performance 7.3.5.3. Product benchmarking 7.3.5.4. Strategic initiatives 7.3.6. FUJIFILM Holdings Corporation 7.3.6.1. Company overview 7.3.6.2. Financial performance 7.3.6.3. Product benchmarking 7.3.6.4. Strategic initiatives 7.3.7. Thermo Fisher Scientific, Inc. 7.3.7.1. Company overview 7.3.7.2. Financial performance 7.3.7.3. Product benchmarking 7.3.7.4. Strategic initiatives 7.3.8. Agilent Technologies, Inc. 7.3.8.1. Company overview 7.3.8.2. Financial performance 7.3.8.3. Product benchmarking 7.3.8.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(healthcare)の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |